entinostat has been researched along with Diabetes Mellitus, Type 2 in 1 studies
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, Y | 1 |
| Li, M | 1 |
| Wang, Y | 1 |
| Liu, X | 1 |
| Zhou, L | 1 |
| Zhang, C | 1 |
| Shao, L | 1 |
1 other study available for entinostat and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Histone deacetylase inhibition by MS-275 potentiates glucose-stimulated insulin secretion without affecting glucose oxidation.
Topics: Animals; Benzamides; Calcium; Cyclic AMP; Diabetes Mellitus, Type 2; Gene Knockdown Techniques; Gluc | 2020 |